<--- Back to Details
First PageDocument Content
Piperazines / Cardiac electrophysiology / QT interval / Adverse Event Reporting System / Torsades de pointes / Breast implant / Norfloxacin / Clinical research / Approved drug / Medicine / Health / Food and Drug Administration
Piperazines
Cardiac electrophysiology
QT interval
Adverse Event Reporting System
Torsades de pointes
Breast implant
Norfloxacin
Clinical research
Approved drug
Medicine
Health
Food and Drug Administration

JOURNAL OF WOMEN’S HEALTH Volume 16, Number 6, 2007 © Mary Ann Liebert, Inc. DOI: [removed]jwh[removed]Special Report

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 87,71 KB

Share Document on Facebook

Similar Documents

Breast Implant Associated Lymphoma  What To Tell Your Patients A special information evening to be presented by

Breast Implant Associated Lymphoma What To Tell Your Patients A special information evening to be presented by

DocID: 1vp5j - View Document

QUALITY  I N N O VAT I O N SERVICE

QUALITY I N N O VAT I O N SERVICE

DocID: 1r3JY - View Document

New York Times Magazine  Amalia Ulman! !

New York Times Magazine Amalia Ulman! !

DocID: 1r2WH - View Document

Breast Cancer Action  ANNUAL REPORT 2004 Creating a Breast Cancer Research Revolution

Breast Cancer Action ANNUAL REPORT 2004 Creating a Breast Cancer Research Revolution

DocID: 1qYsP - View Document

bca_annual report08_print.indd

bca_annual report08_print.indd

DocID: 1qY6e - View Document